Psilocybin uniquely enables psychological exploration, said Dr. Anthony Back, the trial’s lead investigator.
Well, researchers aren’t ignoring it.
Exhausted and burnt out frontline and healthcare workers have been recruited into a University of Washington School of Medicine clinical trial to test whether psilocybin can alleviate their stress and anxiety. Even two years into the worldwide pandemic, infection risks and abrupt quarantines have taken an undeniable toll on the mental health of nurses and doctors alike. This may be a saving grace for the healthcare field with care workers leaving the field in droves, apparently.
Regardless, psilocybin is still recognized as a Schedule 1 substance by the Food and Drug Administration, deeming it without accepted medical use and having a high potential for abuse.
However, mental and physical health continues to wane. Since the 1990’s, psilocybin has been finding accepted medical use in the research and it isn’t stopping. Psilocybin is not being posited as a solution for COVID-19, so perhaps this assertion is still a stretch for the research world. Perhaps its even a stretch for mycophiles and psychonauts, who would be keen to see magic mushrooms be yet another solution to an ailment.